Physician

Mark Letica, MD

According to 2025 Medicare claims, Mark Letica, MD (NPI: 1457315558) practices sleep medicine in the Charlotte-Concord-Gastonia, NC-SC market, with the plurality of this provider's patient population coming from Lincoln, NC. This provider's primary affiliated billing organization is CAROLINAS PHYSICIANS NETWORK INC (NPI: 1558702191; TIN: 561667838) and primary practice location at 28092-4126. Letica is affiliated with the Carolinas HealthCare System ACO, LLC (ACO ID: A3675), participating under the MSSP model.

Letica's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 443 traditional Medicare patients, billed 702 HCPCS/CPT codes, and received $47,137 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 833 prescription claims across 131 beneficiaries totaling $38,011 in drug costs, led by Dextroamphetamine-Amphetamine (Dextroamphetamine/Amphetamine). DME data shows 5,518 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $203,856 to $38,011. For DME billing, reported payments rose steadily, from $139,327 to $214,455.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	316	588	$46,913
2016	298	537	$42,430
2017	278	533	$45,000
2018	312	591	$46,943
2019	342	589	$47,522
2020	331	495	$37,857
2021	332	525	$46,224
2022	409	572	$48,832
2023	414	607	$49,988
2024	443	702	$47,137

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	160	1,132	$203,856
2016	134	1,036	$285,979
2017	145	939	$149,188
2018	144	926	$163,822
2019	122	786	$113,081
2020	124	827	$41,277
2021	127	838	$41,047
2022	130	863	$49,840
2023	127	751	$35,134
2024	131	833	$38,011

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	1,573	3,203	$137,997
2016	1,639	3,353	$123,986
2017	1,450	3,100	$87,765
2018	1,565	3,550	$101,791
2019	1,567	3,546	$113,292
2020	1,583	3,401	$114,888
2021	1,656	3,855	$127,342
2022	1,930	4,199	$155,655
2023	2,154	4,935	$192,087
2024	2,355	5,518	$214,164

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	58	58	$108
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	169	176	$85
95811	Sleep study in sleep lab with continuous airway pressure (6 years or older)	43	48	$83
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	194	200	$60
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	124	126	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	109	3,988	$7,004
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	37	1,590	$3,297
Dextroamphetamine Sulfate Er	Dextroamphetamine Sulfate	19	570	$3,158
Modafinil	Modafinil	48	2,160	$2,704
Armodafinil	Armodafinil	31	1,320	$1,630

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0601	Continuous positive airway pressure (cpap) device	Y	154	914	$30,924
A7030	Full face mask used with positive airway pressure device, each	N	142	297	$25,822
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	216	465	$24,787
A4604	Tubing with integrated heating element for use with positive airway pressure device	N	293	636	$23,471
A7031	Face mask interface, replacement for full face mask, each	N	136	301	$22,375

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Mark Letica, MD?

Tedicare shows public-source Medicare data for Mark Letica, MD (NPI 1457315558), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark Letica, MD have ACO affiliation data?

Mark Letica, MD is shown with ACO affiliation data for Carolinas HealthCare System ACO, LLC (MSSP, ACO ID A3675).

What billing organization is linked to Mark Letica, MD?

Mark Letica, MD is linked to CAROLINAS PHYSICIANS NETWORK INC (billing NPI 1558702191) in the available physician profile data.

Does Mark Letica, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.